Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lasset

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 1, 1993
Prospective multicentric study of the etiology of 1051 bacteremic episodes in 782 cancer patients. CEMIC (French-Belgian Study Club of Infectious Diseases in Cancer)D Coullioud, P Van der Auwera, M Viot, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|October 29, 1998
[The role of the medical corps in a mass screening program for cervical cancer. The program "Female Health Action in 3 urban districts of Lyons]H Mignotte, D Perol, B Fontanière, et al.
Revue D'Epidemiologie Et De Sante Publique|September 10, 2013
Factors associated with Pap smear screening among French women visiting a general practitioner in the Rhône-Alpes regionN Oussaid, D Lutringer-Magnin, G Barone, et al.
Bulletin Du Cancer|January 1, 1992
[Adjuvant therapy of breast cancer with tamoxifen and endometrial carcinoma]H Mignotte, A J Sasco, C Lasset, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 1999
Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a wholeV Cottin, D Arpin, C Lasset, et al.
Bulletin Du Cancer|February 15, 2001
[Reliability of the response rate in oncology: analysis of the causes for variation]S Négrier, L Ollivier, D Di Stefano-Louineau, et al.
American Journal of Clinical Oncology|February 24, 2001
Multicentric phase II study of cisplatin and etoposide in patients with metastatic carcinoma of unknown primaryE Voog, Y Merrouche, V Trillet-Lenoir, et al.
Cancer Research|February 2, 1999
Neurofibromatosis and early onset of cancers in hMLH1-deficient childrenQ Wang, C Lasset, F Desseigne, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|September 16, 2000
[The "Action Woman Health" program in three Lyons suburbs]H Mignotte, M F Le Goaziou, L P Nachury, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase II study of fotemustine as second-line treatment after failure of immunotherapy in metastatic renal cell carcinomaC Lasset, Y Merrouche, S Negrier, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 1, 1993
Prospective multicentric study of the etiology of 1051 bacteremic episodes in 782 cancer patients. CEMIC (French-Belgian Study Club of Infectious Diseases in Cancer)D Coullioud, P Van der Auwera, M Viot, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|October 29, 1998
[The role of the medical corps in a mass screening program for cervical cancer. The program "Female Health Action in 3 urban districts of Lyons]H Mignotte, D Perol, B Fontanière, et al.
Revue D'Epidemiologie Et De Sante Publique|September 10, 2013
Factors associated with Pap smear screening among French women visiting a general practitioner in the Rhône-Alpes regionN Oussaid, D Lutringer-Magnin, G Barone, et al.
Bulletin Du Cancer|January 1, 1992
[Adjuvant therapy of breast cancer with tamoxifen and endometrial carcinoma]H Mignotte, A J Sasco, C Lasset, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 2, 1999
Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a wholeV Cottin, D Arpin, C Lasset, et al.
Bulletin Du Cancer|February 15, 2001
[Reliability of the response rate in oncology: analysis of the causes for variation]S Négrier, L Ollivier, D Di Stefano-Louineau, et al.
American Journal of Clinical Oncology|February 24, 2001
Multicentric phase II study of cisplatin and etoposide in patients with metastatic carcinoma of unknown primaryE Voog, Y Merrouche, V Trillet-Lenoir, et al.
Cancer Research|February 2, 1999
Neurofibromatosis and early onset of cancers in hMLH1-deficient childrenQ Wang, C Lasset, F Desseigne, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|September 16, 2000
[The "Action Woman Health" program in three Lyons suburbs]H Mignotte, M F Le Goaziou, L P Nachury, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase II study of fotemustine as second-line treatment after failure of immunotherapy in metastatic renal cell carcinomaC Lasset, Y Merrouche, S Negrier, et al.
Pageof 7